Cavalier Investments LLC Boosts Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Cavalier Investments LLC grew its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 88.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,436 shares of the biopharmaceutical company’s stock after purchasing an additional 2,084 shares during the […]